Arterial Vascular Engineering AVEI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arterial Vascular Engineering AVEI

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bullw who wrote ()	8/5/1998 10:37:00 AM
From: Sam Armstrong	of 410

From Briefing.com: Updated: 05-Aug-98 09:30 -- 10:00 ET (Updated throughout the hour)****** Arterial Vascular Engineering Inc. (AVEI) 39 3/4 +1/8: Adams Harkness raises estimate on manufacturer of highly specialized stent systems and percutaneous transluminal coronary angioplasty balloon catheters as the Bard acquisition puts company in a strong position; stent prices are still climbing and firm maintains "buy" rating on stock as company is participating in an accelerating market environment at a valuation that assumes the worst case across the board; raises FY99 EPS estimate from $2.13 to $2.80 a share; has an estimate of $3.67 a share for FY00.....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next